Comparison of Low-Dose Rosuvastatin with Atorvastatin in Lipid-Lowering Efficacy and Safety in a High-Risk Pakistani Cohort: An Open-Label Randomized Trial

Background. Treatment of hyperlipidemia is helpful in both primary and secondary prevention of coronary heart disease and stroke. Aim. To compare lipid-lowering efficacy of rosuvastatin with atorvastatin. Methodology. This open-label randomized controlled trial was carried out at 1 Mountain Medical...

Descripción completa

Detalles Bibliográficos
Autor principal: Arshad, Abdul Rehman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3985301/
https://www.ncbi.nlm.nih.gov/pubmed/24800084
http://dx.doi.org/10.1155/2014/875907

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3985301/
https://www.ncbi.nlm.nih.gov/pubmed/24800084
http://dx.doi.org/10.1155/2014/875907

Ejemplares similares